ruboxistaurin has been researched along with acridine orange in 1 studies
| Studies (ruboxistaurin) | Trials (ruboxistaurin) | Recent Studies (post-2010) (ruboxistaurin) | Studies (acridine orange) | Trials (acridine orange) | Recent Studies (post-2010) (acridine orange) |
|---|---|---|---|---|---|
| 203 | 29 | 56 | 2,310 | 19 | 343 |
| Protein | Taxonomy | ruboxistaurin (IC50) | acridine orange (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, Y; Kiryu, J; Miyamoto, K; Nishiwaki, H; Nonaka, A; Ogura, Y; Tsujikawa, A; Yamashiro, K | 1 |
1 other study(ies) available for ruboxistaurin and acridine orange
| Article | Year |
|---|---|
PKC-beta inhibitor (LY333531) attenuates leukocyte entrapment in retinal microcirculation of diabetic rats.
Topics: Acridine Orange; Administration, Oral; Animals; Cell Adhesion; Cell Movement; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Enzyme Inhibitors; Fluorescent Dyes; Fluorophotometry; Indoles; Leukocytes; Male; Maleimides; Microcirculation; Protein Kinase C; Rats; Rats, Long-Evans; Retinal Vessels | 2000 |